Literature DB >> 741654

Biological activity of purified bacteriophage T3 prohead and proheadlike structures as precursors for in vitro head assembly.

J I Miyazaki, H Fujisawa, T Minagawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 741654     DOI: 10.1016/0042-6822(78)90376-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  8 in total

Review 1.  Bacteriophage T3 and bacteriophage T7 virus-host cell interactions.

Authors:  D H Krüger; C Schroeder
Journal:  Microbiol Rev       Date:  1981-03

2.  Involvement of the bacterial groM gene product in bacteriophage T7 reproduction. I. Arrest at the level of DNA packaging.

Authors:  A H Kuhn; M L Moncany; E Kellenberger; R Hausmann
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

3.  In vitro assembly of the Bacillus subtilis bacteriophage phi 29.

Authors:  M A Bjornsti; B E Reilly; D L Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

4.  Bacteriophage phi 29 proteins required for in vitro DNA-gp3 packaging.

Authors:  M A Bjornsti; B E Reilly; D L Anderson
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

5.  Productive phage infection in Escherichia coli with reduced internal levels of the major cations.

Authors:  A Kuhn; E Kellenberger
Journal:  J Bacteriol       Date:  1985-09       Impact factor: 3.490

6.  Bacteriophage P22 in vitro DNA packaging monitored by agarose gel electrophoresis: rate of DNA entry into capsids.

Authors:  R Gope; P Serwer
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

7.  Stability and in vitro DNA packaging of bacteriophages: effects of dextrans, sugars, and polyols.

Authors:  P Serwer; W E Masker; J L Allen
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

8.  In vitro assembly of infectious virions of double-stranded DNA phage phi 29 from cloned gene products and synthetic nucleic acids.

Authors:  C S Lee; P Guo
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.